85-2074-87　NF-kappaB Activation Inhibitor X, Methysticin ((6R)-6-[(1E)-2-(1,3-Benzodioxol-5-yl)ethenyl]-5,6- dihydro-4- methoxy-2H-pyraNF-kappaB Activation Inhibitor X, Methysticin ((6R)-6-[(1E)-2-(1,3-Benzodioxol-5-yl)ethenyl]-5,6- dihydro-4- methoxy-2H-pyran-2-one)n-2-one) 5mg　217586

特徴

• Methysticin has been identified from kava to have potent NF-kB inhibitory activity and minimum toxicity. It is shown to inhibit NF-kB (IC50 = 0.19ug/ml) 100 times more potently than traditional kava in A549 cells in an in vitro luciferase-based assay. It is also reported to suppress the elevation of IKKalpha, p65, and COX-2 and the degradation of IkBalpha in A549 cultures stimulated with TNF-alpha; through Western Blot analysis.
• Synonyms:(6R)-6-[(1E)-2-(1,3-Benzodioxol-5-yl)ethenyl]-5,6- dihydro-4- methoxy-2H-pyran-2-one
• Molecular Formula:C₁₅H₁₄O₅
• Solubility:DMSO
• Molar Mass:274.27
• Storage and Stability:Store at -20°C under inert atmosphere. For maximum recovery of product, centrifuge the original vial prior to removing the cap.

仕様

• Size：5mg
• Grade：Highly Purified
• Purity：≥99% (HPLC)
• Form：Supplied as a white solid.
• Molecular Formula：C₁₅H₁₄O₅
• Molecular Weight Non Ab：274.27
• EU Commodity Code：38220090
• この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
• 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。

• 【試薬に関するお問合せ】
• アズワン株式会社 試薬・プロセス材料グループ
• TEL：06-6447-8641
• FAX：06-6447-8642
• E-mail：[email protected]